ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
Dow Jones
40,589.34
1.64%
US Dollar vs MXN
18.4321
-0.15%
Brent Oil
79.905
-0.83%
Bitcoin
69,598.55
2.66%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
29/07/202406:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PMPhilip Morris International Inc
29/07/202406:02GlobeNewswire Inc.Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial ResultsNASDAQ:OCGNOcugen Inc
29/07/202406:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:OISOil States International Inc
29/07/202406:01Alliance NewsAlliance NewsIN BRIEF: Concurrent Technologies launches new Plug In CardLSE:CNCConcurrent Technologies Plc
29/07/202406:01GlobeNewswire Inc.LuxUrban Hotels Announces Agreement in Principle to Issue Up to $5.0 Million Senior Notes Due 2027NASDAQ:LUXHLuxUrban Hotels Inc
29/07/202406:01Business WireRapid Finance Adds Matthew Thomas as Enterprise Account Executive
29/07/202406:01PR Newswire (US)Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute LeukemiaNASDAQ:SNDXSyndax Pharmaceuticals Inc
29/07/202406:01PR Newswire (US)Leading Midsize Agency, /prompt. Announces Significant Investment in Augmented Intelligence-Powered Strategy Team
29/07/202406:01PR Newswire (US)Tech Mahindra Positioned as a Service Leader in the 2024 SPARK Matrix™ Contact Center Outsourcing Services by Quadrant Knowledge Solutions
29/07/202406:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
29/07/202406:00GlobeNewswire Inc.AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2024NYSE:AMGAffiliated Managers Group Inc
29/07/202406:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
29/07/202406:00Business WireParticular Audience Named in The Leading 100 List, Setting a New Standard in AI-Driven Hyper-Personalization for eCommerce & Retail Media
29/07/202406:00GlobeNewswire Inc.Manhattan Bridge Capital, Inc. Declares Quarterly DividendNASDAQ:LOANManhattan Bridge Capital Inc
29/07/202406:00Business WireNOG Provides Shareholder Return Update; Plans Mid-Year Increase to Quarterly DividendNYSE:NOGNorthern Oil and Gas Inc
29/07/202406:00Business WireSarepta Therapeutics to Announce Second Quarter 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
29/07/202406:00GlobeNewswire Inc.ECARX Announces Board ChangeNASDAQ:ECXECARX Holdings Inc
29/07/202406:00Business WireVirginia State Parks Becomes First in the Nation to Install EnChroma-adapted Viewfinders for Colorblind Guests at Every Park
29/07/202406:00GlobeNewswire Inc.CorVascular’s VasoGuard® Earns FDA 510(k) Clearance
29/07/202406:00Business WireMyrobalan Therapeutics Names Grant Bogle to Board of Directors
29/07/202406:00Business WireGoldenTree Asset Management Hires Head of Real Estate Credit Origination
29/07/202406:00GlobeNewswire Inc.Attralus Receives European Medicines Agency Committee for Orphan Medicinal Products (COMP) Positive Opinions for AT-02 for the Treatment of Both ATTR and AL Amyloidosis
29/07/202406:00Business WireSpear Bio Secures $45 Million in Oversubscribed Series A Financing to Accelerate Product Launch for Protein Research and Disease Diagnostics
29/07/202406:00Business WirePeakstone Realty Trust Amends and Extends Credit FacilityNYSE:PKSTPeakstone Realty Trust
29/07/202406:00GlobeNewswire Inc.Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on PainNASDAQ:RAPPRapport Therapeutics Inc
29/07/202406:00GlobeNewswire Inc.Can-Fite Provides Namodenoson Patent UpdateAMEX:CANFCan Fite BioPharma Ltd
29/07/202406:00GlobeNewswire Inc.Talisker Announces Private Placement of up to $2 MillionTSX:TSKTalisker Resources Ltd
29/07/202406:00Business WireAlliance Resource Partners, L.P. Reports Second Quarter Financial and Operating Results; Declares Quarterly Cash Distribution of $0.70 Per Unit and Updates 2024 GuidanceNASDAQ:ARLPAlliance Resource Partners LP
29/07/202406:00Business WireD-Wave Announces Roadmap to Extend Leap Quantum Cloud Service for AI/MLNYSE:QBTSD Wave Quantum Inc
29/07/202406:00GlobeNewswire Inc.Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ RejectionNASDAQ:ELDNEledon Pharmaceuticals Inc

Su Consulta Reciente

NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
FX
EURUSD
Euro vs US Dollar
NASDAQ
TSLA
Tesla
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados